# Debut Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/debut-biotechnology

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.debutbiotech.com
- Total disclosed funding: $95M
- Latest round: Series B (Oct 19, 2023)
- Investors on record: 15

## About

Debut Biotechnology, Inc. is a US-based company focused on the development of innovative beauty products through advanced biotechnology, offering bio-based ingredients for enhanced performance in beauty applications.Debut Biotechnology, Inc., founded in 2019 and headquartered in San Diego, US, specializes in delivering high-performance beauty solutions. In August 2025, Debut Biotechnology, Inc. raised USD 20 million in venture funding from new investors Sandbox Industries, SG Growth Capital Pte Ltd and Wealthberry. Returning investor Fine Structure Venture, Bold, GS Futures, Material Impact Fund and other unspecified investors also participated in the round. The founder, Gregory Weiss, has a history of involvement in biotechnology ventures, while Joshua Britton serves as the CEO. Debut Biotechnology specializes in developing innovative, scientifically engineered beauty products that leverage advanced biotechnology. The company's core offerings consist of novel, bio-based ingredients that promise heightened performance and functionality in various beauty applications. These ingredients have been clinically tested and are positioned to meet the needs of forward-thinking beauty brands aiming to enhance consumer experiences. Debut's client base includes major beauty brands across North America and Europe, where their products are utilized in skincare, haircare, and cosmetic formulations. These products are designed to address consumer demands for efficacy, sustainability, and personalization, contributing to a transformative experience in the beauty market.Debut Biotechnology generates revenue primarily through partnerships with beauty brands and direct sales of its proprietary ingredients. The business model emphasizes B2B transactions, where beauty brands integrate Debut's ingredients into their product lines. This collaboration often involves long-term partnerships, wherein brands may subscribe to receive continuous access to Debut's innovative ingredients and formulations. While specific pricing plans are not disclosed, the company's transactions are structured around negotiated agreements that reflect the unique value proposition of Debut's flagship products. By providing superior performance and functionality, Debut positions itself as a vital partner in the evolving beauty industry, contributing to both innovation and profitability for its clients.The company plans to utilize the August 2025 funding to drive innovation in skin longevity and expand its formulation operations across the US and Asia.

## Funding rounds

- Series B, Oct 19, 2023, $40M — Bold
- Series B, Mar 7, 2023, $30M — Cultivian Sandbox Ventures, Material Impact Fund, Cavallo Ventures, DIC, Bold, GS Futures, Fine Structure Ventures, ACVC Partners
- Series A, Jul 30, 2021, $23M — Cultivian Sandbox Ventures, Material Impact Fund, Cantos Ventures, KdT Ventures, ACVC, Humboldt Fund, Fine Structure Ventures
- Seed, Dec 19, 2019, $2.6M — Better Ventures, FTW Ventures, KdT Ventures, SpringTide Capital Management
- Seed, Dec 19, 2019, $0.4M — SpringTide Capital Management

## Investors

- Better Ventures — Seed
- FTW Ventures (https://capitalatlas.ai/funds/ftw-ventures) — Seed
- KdT Ventures (https://capitalatlas.ai/funds/kdt-ventures) — Seed, Series A
- SpringTide Capital Management (https://capitalatlas.ai/funds/springtide-capital-management) — Seed
- Cultivian Sandbox Ventures (https://capitalatlas.ai/funds/cultivian-sandbox-ventures) — Series A, Series B
- Material Impact Fund (https://capitalatlas.ai/funds/material-impact-fund) — Series A, Series B
- Cantos Ventures (https://capitalatlas.ai/funds/cantos-ventures) — Series A
- ACVC (https://capitalatlas.ai/funds/acvc) — Series A
- Humboldt Fund (https://capitalatlas.ai/funds/humboldt-fund) — Series A
- Fine Structure Ventures (https://capitalatlas.ai/funds/fine-structure-ventures) — Series A, Series B
- Cavallo Ventures (https://capitalatlas.ai/funds/cavallo-ventures) — Series B
- DIC — Series B
- Bold — Series B
- GS Futures (https://capitalatlas.ai/funds/gs-futures) — Series B
- ACVC Partners (https://capitalatlas.ai/funds/acvc-partners) — Series B